BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25224208)

  • 1. Hepatitis B virus-related immune reconstitution inflammatory syndrome in two patients coinfected with human immunodeficiency virus diagnosed with a liver biopsy.
    Mitsumoto F; Murata M; Kato Y; Ura K; Takayama K; Hiramine S; Ikezaki H; Shimizu M; Toyoda K; Ogawa E; Aishima S; Furusyo N; Hayashi J
    Intern Med; 2014; 53(18):2165-70. PubMed ID: 25224208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of the hepatitis B surface antigen level after the initiation of antiretroviral therapy for hepatitis B virus and human immunodeficiency virus coinfected patients.
    Mitsumoto F; Murata M; Ura K; Takayama K; Hiramine S; Shimizu M; Toyoda K; Ogawa E; Furusyo N; Hayashi J
    J Infect Chemother; 2015 Apr; 21(4):264-71. PubMed ID: 25596071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of hepatitis B virus/human immunodeficiency virus coinfection in a patient who achived hepatitis B surface antigen seroclearance after interferon therapy followed by antiretroviral therapy without developing immune reconstitution inflammatory syndrome].
    Mitsumoto F; Murata M; Ikezaki H; Ogawa E; Taniai H; Toyoda K; Otaguro S; Kainuma M; Okada K; Furusyo N; Hayashi J
    Kansenshogaku Zasshi; 2012 Nov; 86(6):763-7. PubMed ID: 23367852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Immune Reconstitution-Induced Hepatic Flare on Hepatitis B Surface Antigen Loss in Hepatitis B Virus/Human Immunodeficiency Virus-1 Coinfected Patients.
    Yoshikawa S; Yoshio S; Yoshida Y; Tsutsui Y; Kawai H; Yamazoe T; Mori T; Osawa Y; Sugiyama M; Iwamoto M; Watashi K; Kawaguchi T; Akita T; Tanaka J; Kikuchi Y; Mizokami M; Oka S; Kanto T; Gatanaga H
    J Infect Dis; 2021 Jun; 223(12):2080-2089. PubMed ID: 33073291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Reconstitution Syndrome with Initiation of Treatment of HBV/HIV Co-infection: Activity Flare associated with E antigen Seroconversion.
    Rowley MW; Patel A; Zhou W; Wong M; Seetharam AB
    Ann Hepatol; 2019; 18(1):220-224. PubMed ID: 31113594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Immune Reconstitution Inflammatory Syndrome-HBV Flare in an HIV/HBV Coinfected Patient After Antiretroviral Therapy Initiation: Case Report and Literature Review.
    Arshad I; Gandhi M; Gossai M; Feinstein A
    Am J Case Rep; 2023 Apr; 24():e939210. PubMed ID: 37061778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma.
    Tajima K; Kohno K; Shiono Y; Suzuki I; Kato Y; Hiroshima Y; Yamamoto M; Ohtake H; Iwaba A; Yamakawa M; Kato T
    Int J Clin Exp Pathol; 2013; 6(3):536-42. PubMed ID: 23411777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of hepatitis B virus and HIV coinfection.
    Peters MG
    Top HIV Med; 2007; 15(5):163-6. PubMed ID: 18073452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus.
    Dao DY; Balko J; Attar N; Neak E; Yuan HJ; Lee WM; Jain MK
    J Med Virol; 2011 Sep; 83(9):1551-8. PubMed ID: 21739445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
    Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
    J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
    Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
    Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune reconstitution inflammatory syndrome of the small bowel in a human immunodeficiency virus-negative patient.
    Daum S; Loddenkemper C; Schneider T
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):e27-8. PubMed ID: 17628330
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.
    Crane M; Oliver B; Matthews G; Avihingsanon A; Ubolyam S; Markovska V; Chang JJ; Dore GJ; Price P; Visvanathan K; French M; Ruxrungtham K; Lewin SR
    J Infect Dis; 2009 Apr; 199(7):974-81. PubMed ID: 19231993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.
    Boyd A; Moh R; Gabillard D; le Carrou J; Danel C; Anglaret X; Eholié SP; Maylin S; Delaugerre C; Zoulim F; Girard PM; Lacombe K;
    Antivir Ther; 2015; 20(6):643-54. PubMed ID: 25852125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.
    Drake A; Mijch A; Sasadeusz J
    Clin Infect Dis; 2004 Jul; 39(1):129-32. PubMed ID: 15206064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients.
    Pal A; Panigrahi R; Biswas A; Datta S; Sarkar N; Guha SK; Saha B; Banerjee A; Chakrabarti S; Chakravarty R
    Virology; 2013 Feb; 436(1):134-42. PubMed ID: 23228859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An HIV patient with hepatic flare after the initiation of HBV-active antiretroviral therapy.
    Yoshida M; Hoshina T; Tamura K; Kawano S; Kato T; Sato F; Nakazawa Y; Yoshikawa K; Onodera S; Hori S
    Intern Med; 2012; 51(12):1623-6. PubMed ID: 22728503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1.
    Ren G; Esser S; Jochum C; Schlaak JF; Gerken G; Schadendorf D; Dittmer U; Wu G; Yuan Z; Timm J
    AIDS; 2012 Nov; 26(17):2145-53. PubMed ID: 22948268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.
    Coffin CS; Osiowy C; Myers RP; Gill MJ
    J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.